1931: Dr. Otto Warburg wins the Nobel Prize for discovering cancer cells cannot survive without glucose. They're glucose-dependent.

This suggests depriving cancer cells of glucose might treat cancer. Warburg proposes testing therapeutic ketosis: cancer cells need glucose, healthy cells run on ketones.

The hypothesis is brilliant. Clinical trials should begin immediately.

They don't.

Why? Chemotherapy research is exploding. Pharmaceutical companies can patent chemotherapy drugs. They cannot patent "stop eating sugar."

Throughout the 1960s-70s, scattered researchers test ketogenic diets for cancer. Small studies show promising results. Cancer cells shrink when glucose is restricted.

These studies are published in minor journals. No major institution picks them up. No pharmaceutical company funds larger trials.

Dr. Thomas Seyfried at Boston College rediscovers Warburg's work in the 2000s. After 15 years researching cancer metabolism, his conclusion: Cancer is metabolic, not primarily genetic. Ketogenic diets should be first-line therapy.

He publishes "Cancer as a Metabolic Disease" in 2012. Comprehensive. Meticulously researched.

The oncology establishment ignores it completely.

When Seyfried lectures at medical schools, oncologists walk out. They call his work "dangerous." Not because the science is wrong. Because suggesting diet could treat cancer threatens the entire chemotherapy industry.

Current standard cancer treatment: Poison the patient with chemotherapy, then send them home with advice to eat "healthy whole grains" that feed the cancer.

Current research funding for metabolic cancer therapy: Essentially zero.

Warburg won the Nobel Prize 95 years ago. We've known cancer is glucose-dependent since 1962.

We're still feeding cancer patients sugar and calling it supportive care.

Because ketogenic therapy can't be patented.